Pliant Therapeutics Stock Price on October 1, 2024
| PLRX Stock | USD 13.21 0.09 0.68% |
Below is the normalized historical share price chart for Pliant Therapeutics extending back to June 03, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pliant Therapeutics stands at 13.21, as last reported on the 20th of December, with the highest price reaching 13.85 and the lowest price hitting 13.07 during the day.
If you're considering investing in Pliant Stock, it is important to understand the factors that can impact its price. Pliant Therapeutics appears to be not too volatile, given 3 months investment horizon. Pliant Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0785, which implies the firm had a 0.0785% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pliant Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Pliant Therapeutics' Semi Deviation of 3.23, risk adjusted performance of 0.0417, and Coefficient Of Variation of 2359.43 to confirm if our risk estimates are consistent with your expectations.
At this time, Pliant Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 6,038 in 2024, whereas Common Stock is likely to drop 3,143 in 2024. . At this time, Pliant Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.36 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (6.26). Pliant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of June 2020 | 200 Day MA 13.1688 | 50 Day MA 14.0088 | Beta 1.087 |
Pliant |
Sharpe Ratio = 0.0785
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PLRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Pliant Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pliant Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.4644 | Enterprise Value Ebitda (2.54) | Price Sales 3.1 K | Shares Float 46.9 M | Wall Street Target Price 40.1818 |
Related Headline
Stoke Therapeutics Headline on 1st of October 2024
Filed transaction by Stoke Therapeutics Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Pliant Therapeutics Valuation on October 1, 2024
It is possible to determine the worth of Pliant Therapeutics on a given historical date. On October 1, 2024 Pliant was worth 11.15 at the beginning of the trading date compared to the closed value of 10.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pliant Therapeutics stock. Still, in general, we apply an absolute valuation method to find Pliant Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pliant Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pliant Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 11.25 | 11.43 | 10.96 | 11.21 | 240,601 | |
10/01/2024 | 11.15 | 11.15 | 10.46 | 10.55 | 847,996 |
| 10.41 | 10.98 | 10.22 | 10.91 | 309,170 |
| Backtest Pliant Therapeutics | | | Pliant Therapeutics History | | | Pliant Therapeutics Valuation | Previous | Next |
Pliant Therapeutics Trading Date Momentum on October 1, 2024
| On October 02 2024 Pliant Therapeutics was traded for 10.91 at the closing time. The top price for the day was 10.98 and the lowest listed price was 10.22 . The trading volume for the day was 309.2 K. The trading history from October 2, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 3.41% . The trading delta at closing time against the current closing price is 9.95% . |
Pliant Therapeutics Fundamentals Correlations and Trends
By evaluating Pliant Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pliant Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pliant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pliant Therapeutics Stock history
Pliant Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pliant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pliant Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pliant Therapeutics stock prices may prove useful in developing a viable investing in Pliant Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.7 M | 41.1 M | |
| Net Loss | -111 M | -105.4 M |
Pliant Therapeutics Quarterly Net Working Capital |
|
Pliant Therapeutics Stock Technical Analysis
Pliant Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pliant Therapeutics Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Pliant Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pliant Therapeutics December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Pliant Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pliant Therapeutics shares will generate the highest return on investment. By undertsting and applying Pliant Therapeutics stock market strength indicators, traders can identify Pliant Therapeutics entry and exit signals to maximize returns
Pliant Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pliant Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Pliant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pliant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0417 | |||
| Jensen Alpha | 0.1191 | |||
| Total Risk Alpha | 0.0434 | |||
| Sortino Ratio | 0.0418 | |||
| Treynor Ratio | 0.0833 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pliant Stock Analysis
When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.